Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis. Colombo AL, De Almeida JN, Lewis RE, Kontoyiannis DP, et al. J Antimicrob Chemother 2022 Sep 5. pii: 6691804. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Colombo AL, De Almeida JN, Lewis RE, Kontoyiannis DP, et al. Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis. J Antimicrob Chemother 2022 Sep 5. pii: 6691804. doi: 10.1093.
PMID: 36059133